Rx drug information, pharmaceutical research, clinical trials, news, and more
A drug interaction study was performed in which ERBITUX was administered in combination with irinotecan. There was no evidence of any pharmacokinetic interactions between ERBITUX and irinotecan.
Single doses of ERBITUX higher than 500 mg/m2 have not been tested. There is no experience with overdosage in human clinical trials.
All Rights reserved - Copyright DrugLib.com, 2006-2012